Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a phase 2 trial. The Bay Area-based biotech unveiled its ambition earlier ...

The overhead view is of me in a maze.” I don’t know what it says about me that the great Trey Anastasio and Tom Marshall of ...

It’s an easy enough mistake to make ... Read the fine print and bone up on new regulations. The downtown parking maze is about to get a whole lot more confusing.

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins Some states have laws and ethical rules regarding solicitation and ...

I'm a Fitness & Nutrition writer for CNET who enjoys reviewing the latest fitness gadgets, testing out activewear and sneakers, as well as debunking wellness myths. On my spare time I enjoy ...

Despite best-in-class object recognition, the overall cleaning experience for the Narwal Freo Z Ultra is a big let down.

Thanks to a weak yen, Tokyo has become a surprisingly affordable vacation spot for American travelers—and you don’t even have ...

DeepSeek's DeepThink R1 built a playable Pac-Man game in minutes with minimal input. We tested its reasoning, coding, and ...

How can I apply AI to, you know, teaching?" Huang's advice to future generations is simple: Learn how to use the technology in its various forms, including how to craft smart prompts. "If I were a ...

The Simple Sabotage Field Manual teaches that to bring down an organization you must insist on strict processes, excessive ...